Not actual patient.
Not actual patient.
PEDMARK helps protect a person’s hearing from the risk of cisplatin-related hearing loss. This kind of hearing loss happens when cisplatin builds up in the cochlea (the part of the inner ear shaped like a spiral).
Cisplatin destroys the tiny hairs in the cochlea that mainly control hearing. Once these hairs are destroyed, they do not grow back. That means that any hearing loss lasts forever.
It isn’t known exactly how PEDMARK works, but scientists think it may:
Fennec HEARS™ is the single source for both financial and patient support. Call 1-833-7PEDMARK.
Find helpful tools and resources.
Please see full Prescribing Information, including Patient Information, for PEDMARK.
PEDMARK is a prescription medicine used to decrease the risk of hearing loss in children 1 month of age and older who are receiving cisplatin for solid tumors (cancer) that have not spread to other parts of the body.
It is not known if PEDMARK is safe and effective when given after cisplatin infusions longer than 6 hours.
It is not known if PEDMARK is safe and effective in children less than 1 month of age. PEDMARK is not recommended in children younger than 1 month of age.